JPJ (TCM) Limited

保济元和(TCM)有限公司

Hong Kong-based proprietary Chinese medicine group selling branded PCM products such as Po Chai Pills and medicated oils, and operating Chinese medicine clinics; ranked first in the Hong Kong PCM market with 9.2% share by end-market sales in 2025, per Frost & Sullivan.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Distribution model
• Single product, business line or region
• Raw material and commodity prices
• Outsourced production (OEM / contract manufacturing)
• Business changes and acquisitions
• Key long-term agreements
• Capacity and utilisation
• Reliance on the controlling shareholder
• Net current liabilities or net liabilities
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Non-recurring gains and losses
• Related-party transactions and balances